ÖZKAN, M. H. Et Al. 2014. beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery. 11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges , (Banff, Canada), 143.

ÖZKAN, M. H., DOĞAN, F. E., & Uma, S., (2014). beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery . 11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges (pp.143). Banff, Canada

ÖZKAN, MELİKE, FATMA ENİSE DOĞAN, And Serdar Uma. "beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery," 11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges, Banff, Canada, 2014

ÖZKAN, MELİKE H. Et Al. "beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery." 11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges , Banff, Canada, pp.143, 2014

ÖZKAN, M. H. DOĞAN, F. E. And Uma, S. (2014) . "beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery." 11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges , Banff, Canada, p.143.

@conferencepaper{conferencepaper, author={MELİKE HACER ÖZKAN Et Al. }, title={beta 2-adrenoceptor antagonist ICI 118,551 selectively increases IKCa channel-mediated vasodilation in rat main mesenteric artery}, congress name={11th International Symposium on Resistance Arteries from Molecular Machinery to Clinical Challenges}, city={Banff}, country={Canada}, year={2014}, pages={143} }